Atara Biotherapeutics (ATRA) Treasury Shares (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Treasury Shares of $322690.0 for Q1 2026, up 49.36% on a QoQ basis from $216048.0 in Q4 2025, and down 52.4% year-over-year from $677948.0 in Q1 2025.
Atara Biotherapeutics (ATRA) Treasury Shares (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Treasury Shares history runs 14 years deep, the most recent figure standing at $322690.0 for Q1 2026.
- Quarterly Treasury Shares fell 52.4% year-over-year to $322690.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $322690.0 (down 52.4% YoY) and the FY2025 annual result came in at $216048.0, down 47.87% from the prior year.
- Treasury Shares was $322690.0 for Q1 2026 at Atara Biotherapeutics, up from $216048.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $16.5 million in Q1 2024 and bottomed at $216048.0 in Q4 2025.
- A 5-year average of $4.7 million and a median of $677948.0 in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares tumbled 96.26% — and 2024, when it soared 65.32%.
- Atara Biotherapeutics' Treasury Shares stood at $6.7 million in 2022, then tumbled by 96.26% to $250709.0 in 2023, then surged by 65.32% to $414470.0 in 2024, then tumbled by 47.87% to $216048.0 in 2025, then jumped by 49.36% to $322690.0 in 2026.
- Business Quant data shows ATRA's Treasury Shares at $322690.0 in Q1 2026, $216048.0 in Q4 2025, and $278347.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 322,690.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 322,690.00 |
| Mar 31, 2026 | 322,690.00 |
| Dec 31, 2025 | 216,048.00 |
| Dec 31, 2025 | 216,048.00 |
| Sep 30, 2025 | 278,347.00 |
| Sep 30, 2025 | 278,347.00 |
| Jun 30, 2025 | 503,640.00 |
| Jun 30, 2025 | 503,640.00 |
| Mar 31, 2025 | 677,948.00 |
| Mar 31, 2025 | 677,948.00 |
| Dec 31, 2024 | 414,470.00 |
| Dec 31, 2024 | 414,470.00 |
| Sep 30, 2024 | 517,400.00 |
| Sep 30, 2024 | 517,400.00 |
| Jun 30, 2024 | 554,938.00 |
| Jun 30, 2024 | 554,938.00 |
| Mar 31, 2024 | 16.47 Mn |
| Mar 31, 2024 | 16.47 Mn |
| Dec 31, 2023 | 250,709.00 |
| Dec 31, 2023 | 250,709.00 |